Final analysis of the efficacy and safety of omacetaxine mepesuccinate in patients with chronic‐ or accelerated‐phase chronic myeloid leukemia: Results with 24 months of follow‐up

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|10|1637-1644

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.10, 2015-05, pp. : 1637-1644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long‐term 9‐year follow‐up of 134 patients

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : E95-E96

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tolerability and efficacy of pegylated interferon‐α‐2a in combination with imatinib for patients with chronic‐phase chronic myeloid leukemia

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4284-4289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Accelerated Phase of Chronic Myeloid Leukemia Presenting with Hypercalcemia and a Mediastinal Mass

By  

Acta Haematologica, Vol. 99, Iss. 4, 1998-05 ,pp. : 231-233

Karger

Access to resources Recommend Favorite

Perioperative and follow-up results in chronic pancreatitis patients after pancreatic resection

By Kaťuchová Jana  

Wiener klinische Wochenschrift, Vol. 123, Iss. 11-12, 2011-06 ,pp. : 359-363

Springer Publishing Company

Access to resources Recommend Favorite

Dasatinib for the treatment of chronic phase chronic myeloid leukemia

By Campbell Victoria   Copland Mhairi  

Clinical Practice, Vol. 10, Iss. 4, 2013-07 ,pp. : 415-425

Future Medicine

Access to resources Recommend Favorite